Literature DB >> 28964772

Prion-like transmission of α-synuclein pathology in the context of an NFL null background.

Nicola J Rutherford1, Mieu Brooks2, Cara J Riffe3, Kimberly-Marie M Gorion4, Jasie K Howard5, Jess-Karan S Dhillon6, Benoit I Giasson7.   

Abstract

Neurofilaments are a major component of the axonal cytoskeleton in neurons and have been implicated in a number of neurodegenerative diseases due to their presence within characteristic pathological inclusions. Their contributions to these diseases are not yet fully understood, but previous studies investigated the effects of ablating the obligate subunit of neurofilaments, low molecular mass neurofilament subunit (NFL), on disease phenotypes in transgenic mouse models of Alzheimer's disease and tauopathy. Here, we tested the effects of ablating NFL in α-synuclein M83 transgenic mice expressing the human pathogenic A53T mutation, by breeding them onto an NFL null background. The induction and spread of α-synuclein inclusion pathology was triggered by the injection of preformed α-synuclein fibrils into the gastrocnemius muscle or hippocampus in M83 versus M83/NFL null mice. We observed no difference in the post-injection time to motor-impairment and paralysis endpoint or amount and distribution of α-synuclein inclusion pathology in the muscle injected M83 and M83/NFL null mice. Hippocampal injected M83/NFL null mice displayed subtle region-specific differences in the amount of α-synuclein inclusions however, pathology was observed in the same regions as the M83 mice. Overall, we observed only minor differences in the induction and transmission of α-synuclein pathology in these induced models of synucleinopathy in the presence or absence of NFL. This suggests that NFL and neurofilaments do not play a major role in influencing the induction and transmission of α-synuclein aggregation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  NFL gene (NEFL) knockout; Neurofilaments; Parkinson’s disease; Synucleinopathy; Transgenic mice; α-Synuclein

Mesh:

Substances:

Year:  2017        PMID: 28964772      PMCID: PMC5813496          DOI: 10.1016/j.neulet.2017.09.054

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  52 in total

1.  Two monoclonal antibodies recognize Alzheimer's neurofibrillary tangles, neurofilament, and microtubule-associated proteins.

Authors:  H Ksiezak-Reding; S H Yen
Journal:  J Neurochem       Date:  1987-02       Impact factor: 5.372

2.  Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments.

Authors:  Q Zhu; S Couillard-Després; J P Julien
Journal:  Exp Neurol       Date:  1997-11       Impact factor: 5.330

3.  Lewy bodies.

Authors:  L S Forno
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

4.  Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments.

Authors:  T Ishihara; M Higuchi; B Zhang; Y Yoshiyama; M Hong; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

5.  Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles.

Authors:  M L Schmidt; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

Review 6.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

7.  Neurofilament inclusion body disease with early onset frontotemporal dementia and primary lateral sclerosis.

Authors:  I R A Mackenzie; H Feldman
Journal:  Clin Neuropathol       Date:  2004 Jul-Aug       Impact factor: 1.368

8.  Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations.

Authors:  E Wu; D W Dickson; S Jacobson; C S Raine
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Neurofilament gene expression: a major determinant of axonal caliber.

Authors:  P N Hoffman; D W Cleveland; J W Griffin; P W Landes; N J Cowan; D L Price
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.

Authors:  Oskar Hansson; Shorena Janelidze; Sara Hall; Nadia Magdalinou; Andrew J Lees; Ulf Andreasson; Niklas Norgren; Jan Linder; Lars Forsgren; Radu Constantinescu; Henrik Zetterberg; Kaj Blennow
Journal:  Neurology       Date:  2017-02-08       Impact factor: 9.910

View more
  1 in total

1.  Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.

Authors:  Jess-Karan S Dhillon; Jorge A Trejo-Lopez; Cara Riffe; Yona Levites; Amanda N Sacino; David R Borchelt; Anthony Y Yachnis; Benoit I Giasson
Journal:  Acta Neuropathol Commun       Date:  2019-05-20       Impact factor: 7.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.